Nimotop

Active Ingredient(s): Nimodipine
FDA Approved: * December 28, 1988
Pharm Company: * BAYER PHARMS
Category: Blood Pressure

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Nimotop Overview

Nimodipine, sold under the brand name Nimotop among others, is a calcium channel blocker used in preventing vasospasm secondary to subarachnoid hemorrhage (a form of cerebral hemorrhage). It was originally developed for the treatment of high blood pressure, but is not used for this indication. It was patented in 1971[2] and approved for medical use in the US in 1988.[3] It was approved for medical use in Germany in 1985.[4] Contents 1 Medical ...

Read more Nimotop Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Nimodipine

Recent Nimotop Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Nimodipine
  • Capsule: 30mg
  • Solution: 3mg/ml, 60mg/20ml, 6mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Nimodipine or a similar ingredient: (2 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 1 March 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA